In Vitro Diagnostics Market Demand, Scope and Global Competitive Insights 2025

1
Technology - Point of Care, Molecular
Diagnostics, Immunoassays, Clinical Chemistry,
Whole Blood Glucose Monitoring, Hematology,
Clinical Microbiology, and Coagulation and
Hemostasis Application - Drug Testing,
Infectious Disease, Oncology, Metabolic Disease,
and Autoimmune Disease End User - Diagnostics
Laboratories, Hospitals, Academic Research
Centers, and Home CareForecast 2017 - 2025
In Vitro Diagnostics Market
2
Table of Content
Sr. No. Content
Chapter1 Preface
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Executive Summary
Chapter 5 Market Overview
Chapter 6 Market Dynamics 
Chapter 7 Global In Vitro Diagnostics Market Analysis By Technology Type
Chapter 8 Global In Vitro Diagnostic Market Analysis, by Application
Chapter 9 Global In Vitro Diagnostic Market Analysis, by End Users
Chapter 10 Global In Vitro Diagnostics Market Analysis, by Region
Chapter 11 North America In Vitro Diagnostic Market Analysis
Chapter 12 Europe In Vitro Diagnostic Market Analysis
Chapter 13 Asia Pacific In Vitro Diagnostic Market Analysis
Chapter 14 Latin America In Vitro Diagnostic Market Analysis
Chapter 15 Middle East Africa In Vitro Diagnostic Market Analysis
Chapter 16 Company Profiles
3
In Vitro Diagnostics Market Snapshot

• The development of the condition-specific tests
  and markers and the rise in the adoption of
  point-of-care testing are projected to support
  the growth of the Market.
• A tremendous rise in the geriatric population and
  the increasing prevalence of infectious and
  chronic diseases are estimated to support the
  growth of the global in vitro diagnostics market
  in the next few years.
• By technology type market further segmented into
  point of care, molecular diagnostics,
  immunoassays, clinical chemistry, whole blood
  glucose monitoring, hematology, clinical
  microbiology, coagulation and hemostasis, and
  others.

4
(No Transcript)
5
Reports Highlights

• Global market for in vitro diagnostics was worth
  US55000 mn and is projected to reach a value of
  US89862.2 mn by the end of 2025. The market is
  projected to register a healthy 5.60 CAGR
  between 2017 and 2025
• The key findings section included in the report
  would assist existing market players in expanding
  their market shares, and new companies in
  establishing their presence in the global In
  Vitro Diagnostics Market. The key players
  operating in the in vitro diagnostics market are
  Abbott., Becton Dickinson and Company
• Application - Drug Testing, Infectious Disease,
  Oncology, Metabolic Disease, Autoimmune Disease,
  Others

Request Sample
6
Continue..

• In September, 2017, Amgen Inc. And ALLERGAN
  Collectively Obtained FDA Approval For The Use Of
  MVASI To Treat Five Types Of Cancer.
• Continuous Launch Of New Products And Increase In
  The Number Of Patients In Developed And
  Developing Countries.
• Expansion Of Drugs Delivery System Portfolio By
  Improving Existing Drug Delivery Devices And
  Developing And Launching Of New Drug Delivery
  System Through Collaboration.

Request Brochure
7
(No Transcript)